Reverse Transcriptase Inhibitors

Reverse transcriptase inhibitors (RTIs) are a group of antiviral drugs used to treat HIV/AIDS, hepatitis B, and other viral infections. RTIs work by preventing reverse transcriptase, a viral enzyme, from copying the genetic material (RNA) of a virus into the genetic material (DNA) of a host cell. This prevents the virus from replicating and spreading within the body. RTIs are a key part of antiretroviral therapies that help reduce the spread of HIV and improve the quality of life for people living with HIV/AIDS.


From: International Journal of Personalized Medicine

Related Article For "Reverse Transcriptase Inhibitors"

About (6) results

Article:

A Rare Cause of Fever of Unknown Origin: Reverse Shapiro’s Syndrome

Journal:

Preventive Medicine And Care

Article:

Docking Studies of HIV-1 Reverse Transcriptase and HIV-1 Protease with Phytocompounds of Carissa Carandas L.

Journal:

Clinical Research In HIV AIDS And Prevention

Article:

Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Induce Aging by Inhibiting Telomerase Function

Journal:

Clinical Research In HIV AIDS And Prevention

Article:

Stem Cell Differentiation Stage Factors (SCDSFs) Taken from Zebrafish Embryo during Organogenesis and their Role as Epigenetics Regulators able to Reverse Neurosensory Hearing Loss

Journal:

Otolaryngology Advances

Article:

Cross-Reactivity between COX-2 Inhibitors in Patients with Cross-Reactive Hypersensitivity to NSAIDs

Journal:

Public Health International

Article:

Natural Polyphenols as Inhibitors for the Binding of Covid-19 S-RBD with ACE-2

Journal:

Human Health Research